ALXN
LSV Asset Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-1,710,802
| Closed | -$314M | – | 934 |
|
|
2021
Q2 | $314M | Sell |
1,710,802
-888,580
| -34% | -$163M | 0.53% | 48 |
|
|
2021
Q1 | $397M | Sell |
2,599,382
-760,704
| -23% | -$116M | 0.68% | 32 |
|
|
2020
Q4 | $525M | Sell |
3,360,086
-182,812
| -5% | -$28.6M | 0.95% | 16 |
|
|
2020
Q3 | $405M | Buy |
3,542,898
+43,464
| +1% | +$4.97M | 0.83% | 24 |
|
|
2020
Q2 | $393M | Buy |
3,499,434
+2,650,007
| +312% | +$297M | 0.81% | 26 |
|
|
2020
Q1 | $76.3M | Buy |
849,427
+178,677
| +27% | +$16M | 0.18% | 143 |
|
|
2019
Q4 | $72.5M | Buy |
670,750
+661,950
| +7,522% | +$71.6M | 0.11% | 211 |
|
|
2019
Q3 | $861K | Buy |
+8,800
| New | +$861K | ﹤0.01% | 759 |
|